• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对恶性疟原虫 GST 的从头抑制剂设计方法的开发与应用

Development and application of fragment-based de novo inhibitor design approaches against Plasmodium falciparum GST.

机构信息

College of Pharmacy, Knowledge University, Erbil, Iraq.

College of Pharmacy, Ninevah University, Mosul, Iraq.

出版信息

J Mol Model. 2023 Aug 16;29(9):281. doi: 10.1007/s00894-023-05650-0.

DOI:10.1007/s00894-023-05650-0
PMID:37584781
Abstract

CONTEXT

Modulation of disease progression is frequently started by identifying biochemical pathway catalyzed by biomolecule that is prone to inhibition by small molecular weight ligands. Such ligands (leads) can be obtained from natural resources or synthetic libraries. However, de novo design based on fragments assembly and optimization is showing increasing success. Plasmodium falciparum parasite depends on glutathione-S-transferase (PfGST) in buffering oxidative heme as an approach to resist some antimalarials. Therefore, PfGST is considered an attractive target for drug development. In this research, fragment-based approaches were used to design molecules that can fit to glutathione (GSH) binding site (G-site) of PfGST.

METHODS

The involved approaches build molecules from fragments that are either isosteric to GSH sub-moieties (ligand-based) or successfully docked to GSH binding sub-pockets (structure-based). Compared to reference GST inhibitor of S-hexyl GSH, ligands with improved rigidity, synthetic accessibility, and affinity to receptor were successfully designed. The method involves joining fragments to create ligands. The ligands were then explored using molecular docking, Cartesian coordinate's optimization, and simplified free energy determination as well as MD simulation and MMPBSA calculations. Several tools were used which include OPENEYE toolkit, Open Babel, Autodock Vina, Gromacs, and SwissParam server, and molecular mechanics force field of MMFF94 for optimization and CHARMM27 for MD simulation. In addition, in-house scripts written in Matlab were used to control fragments connection and automation of the tools.

摘要

背景

通过识别易于被小分子配体抑制的生物分子催化的生化途径,通常可以开始调节疾病进展。这些配体(先导化合物)可以从自然资源或合成文库中获得。然而,基于片段组装和优化的从头设计正在显示出越来越多的成功。疟原虫寄生虫依赖谷胱甘肽-S-转移酶(PfGST)来缓冲氧化血红素,作为抵抗一些抗疟药物的一种方法。因此,PfGST 被认为是药物开发的一个有吸引力的靶点。在这项研究中,基于片段的方法被用于设计可以适应 PfGST 谷胱甘肽(GSH)结合位点(G 位点)的分子。

方法

所涉及的方法从与 GSH 亚基(基于配体)等排或成功对接 GSH 结合亚袋(基于结构)的片段构建分子。与 S-己基 GSH 的参考 GST 抑制剂相比,成功设计了具有改善的刚性、合成可及性和与受体亲和力的配体。该方法涉及连接片段以创建配体。然后使用分子对接、笛卡尔坐标优化、简化自由能确定以及 MD 模拟和 MMPBSA 计算来探索这些配体。使用了几个工具,包括 OPENEYE 工具包、Open Babel、Autodock Vina、Gromacs 和 SwissParam 服务器,以及 MMFF94 用于优化和 CHARMM27 用于 MD 模拟的分子力学力场。此外,还使用了在 Matlab 中编写的内部脚本来控制片段连接和工具的自动化。

相似文献

1
Development and application of fragment-based de novo inhibitor design approaches against Plasmodium falciparum GST.针对恶性疟原虫 GST 的从头抑制剂设计方法的开发与应用
J Mol Model. 2023 Aug 16;29(9):281. doi: 10.1007/s00894-023-05650-0.
2
Assembly of ligands interaction models for glutathione-S-transferases from Plasmodium falciparum, human and mouse using enzyme kinetics and molecular docking.利用酶动力学和分子对接构建恶性疟原虫、人和小鼠谷胱甘肽 - S - 转移酶的配体相互作用模型。
Comput Biol Chem. 2016 Oct;64:237-249. doi: 10.1016/j.compbiolchem.2016.07.007. Epub 2016 Jul 25.
3
Plasmodium falciparum glutathione S-transferase--structural and mechanistic studies on ligand binding and enzyme inhibition.恶性疟原虫谷胱甘肽S-转移酶——配体结合与酶抑制的结构及机制研究
Protein Sci. 2006 Feb;15(2):281-9. doi: 10.1110/ps.051891106. Epub 2005 Dec 29.
4
Calorimetric studies of ligands binding to glutathione S-transferase from the malarial parasite Plasmodium falciparum.对疟原虫 Plasmodium falciparum 谷胱甘肽 S-转移酶与配体结合的量热研究。
Biochemistry. 2013 Mar 19;52(11):1980-9. doi: 10.1021/bi400007g. Epub 2013 Mar 7.
5
Glutathione mediated regulation of oligomeric structure and functional activity of Plasmodium falciparum glutathione S-transferase.谷胱甘肽介导的恶性疟原虫谷胱甘肽S-转移酶寡聚体结构和功能活性的调控
BMC Struct Biol. 2007 Oct 17;7:67. doi: 10.1186/1472-6807-7-67.
6
Glutathione S-transferase of the malarial parasite Plasmodium falciparum: characterization of a potential drug target.恶性疟原虫的谷胱甘肽S-转移酶:一种潜在药物靶点的特性研究
Biol Chem. 2002 May;383(5):821-30. doi: 10.1515/BC.2002.086.
7
Glutathione S-transferase from malarial parasites: structural and functional aspects.疟原虫谷胱甘肽S-转移酶:结构与功能方面
Methods Enzymol. 2005;401:241-53. doi: 10.1016/S0076-6879(05)01015-3.
8
High resolution structures of Plasmodium falciparum GST complexes provide novel insights into the dimer-tetramer transition and a novel ligand-binding site.恶性疟原虫谷胱甘肽S-转移酶复合物的高分辨率结构为二聚体-四聚体转变及一个新的配体结合位点提供了新见解。
J Struct Biol. 2015 Sep;191(3):365-75. doi: 10.1016/j.jsb.2015.06.008. Epub 2015 Jun 10.
9
Identification of novel Plasmodium falciparum PI4KB inhibitors as potential anti-malarial drugs: Homology modeling, molecular docking and molecular dynamics simulations.鉴定新型恶性疟原虫 PI4KB 抑制剂作为潜在抗疟药物:同源建模、分子对接和分子动力学模拟。
Comput Biol Chem. 2019 Jun;80:79-89. doi: 10.1016/j.compbiolchem.2019.03.010. Epub 2019 Mar 23.
10
Multi-target molecular dynamic simulations reveal glutathione-S-transferase as the most favorable drug target of knipholone in .多靶标分子动力学模拟揭示谷胱甘肽-S-转移酶是 knipholone 的最具优势的药物靶标。
J Biomol Struct Dyn. 2023;41(22):12808-12824. doi: 10.1080/07391102.2023.2175378. Epub 2023 Feb 8.

引用本文的文献

1
and Studies of β-Sitosterol Nanoparticles as a Potential Therapy for Isoprenaline-Induced Cognitive Impairment in Myocardial Infarction, Targeting Myeloperoxidase.以及β-谷甾醇纳米颗粒作为针对髓过氧化物酶治疗异丙肾上腺素诱导的心肌梗死认知障碍的潜在疗法的研究。
Pharmaceuticals (Basel). 2024 Aug 21;17(8):1093. doi: 10.3390/ph17081093.
2
Potential preventative impact of aloe-emodin nanoparticles on cerebral stroke-associated myocardial injury by targeting myeloperoxidase: In supporting with and studies.通过靶向髓过氧化物酶,芦荟大黄素纳米颗粒对脑卒中介导的心肌损伤的潜在预防作用:支持[具体研究1]和[具体研究2]的研究。 (注:原文中“and studies”表述不完整,推测是想表达“支持某两项研究”,这里按此意思翻译,你可根据实际情况修改。)
Heliyon. 2024 Jun 15;10(12):e33154. doi: 10.1016/j.heliyon.2024.e33154. eCollection 2024 Jun 30.

本文引用的文献

1
Fragment-to-lead tailored in silico design.基于片段的先导化合物定制化计算机辅助设计。
Drug Discov Today Technol. 2021 Dec;40:44-57. doi: 10.1016/j.ddtec.2021.08.005. Epub 2021 Sep 3.
2
De novo molecular design and generative models.从头分子设计与生成模型。
Drug Discov Today. 2021 Nov;26(11):2707-2715. doi: 10.1016/j.drudis.2021.05.019. Epub 2021 Jun 1.
3
AutoGrow4: an open-source genetic algorithm for de novo drug design and lead optimization.AutoGrow4:一种用于从头药物设计和先导化合物优化的开源遗传算法。
J Cheminform. 2020 Apr 17;12(1):25. doi: 10.1186/s13321-020-00429-4.
4
Assessing Molecular Docking Tools to Guide Targeted Drug Discovery of CD38 Inhibitors.评估分子对接工具以指导针对 CD38 抑制剂的靶向药物发现。
Int J Mol Sci. 2020 Jul 22;21(15):5183. doi: 10.3390/ijms21155183.
5
Application of MM-PBSA Methods in Virtual Screening.MM-PBSA 方法在虚拟筛选中的应用。
Molecules. 2020 Apr 23;25(8):1971. doi: 10.3390/molecules25081971.
6
Improving Protein-Ligand Docking Results with High-Throughput Molecular Dynamics Simulations.利用高通量分子动力学模拟提高蛋白配体对接结果。
J Chem Inf Model. 2020 Apr 27;60(4):2189-2198. doi: 10.1021/acs.jcim.0c00057. Epub 2020 Apr 10.
7
MoleGear: A Java-Based Platform for Evolutionary De Novo Molecular Design.摩尔齿轮:一个基于 Java 的进化从头分子设计平台。
Molecules. 2019 Apr 11;24(7):1444. doi: 10.3390/molecules24071444.
8
Structural Simplification of Natural Products.天然产物的结构简化。
Chem Rev. 2019 Mar 27;119(6):4180-4220. doi: 10.1021/acs.chemrev.8b00504. Epub 2019 Feb 7.
9
Computational Fragment-Based Drug Design: Current Trends, Strategies, and Applications.基于片段的药物计算机辅助设计:当前趋势、策略和应用。
AAPS J. 2018 Apr 9;20(3):59. doi: 10.1208/s12248-018-0216-7.
10
Molecular de-novo design through deep reinforcement learning.通过深度强化学习进行分子从头设计。
J Cheminform. 2017 Sep 4;9(1):48. doi: 10.1186/s13321-017-0235-x.